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LOCAL IZAT ION OF T25 GLYCOPROTEIN  IN WILD-TYPE 
AND THY 1- MUTANT CELLS 
BY IMMUNOFLUORESCENCE AND IMMUNOELECTRON 
MICROSCOPY*  
BY LILLY Y. W. BOURGUIGNON,$ ROBERT HYMAN,§ IAN TROWBRIDGE,II 
AND S. J. SINGER¶ 
(From the Department ofBiology, University of California, La Jolla, California 92093, and 
Cancer Biology Laboratory, Salk Institute, Box 1809, San Diego, California 92112) 
The steps in the biosynthesis of cell membrane glycoproteins and their 
transport to the cell surface are not well understood. We have been studying a
series of mutant cell lines which have blocks in their cell surface expression of 
T25, a membrane glycoprotein bearing the Thy 1 alloantigen (1, 2). Biochemical 
characterization f the nature of the blocks should provide information about 
specific steps in cell membrane glycoprotein biosynthesis. 
Five classes of Thy 1- mutants have been identified by complementation analysis (2, 
3). In somatic ell hybridization studies, mutants of each class complement mutants of 
all other classes but do not complement o her mutants of the same class. The genetic 
studies are consistent with the hypothesis that one mutant class (class D) defines the 
structural gene coding for the Thy 1 alloantigenic determinant. The four remaining 
classes (A, B, C, and E) define genes other than that coding for the Thy 1 determinant 
but whose action is necessary for expression of Thy 1 on the cell surface. 
The Thy 1 alloantigenic determinant is borne on a glycoprotein ofapproximate mol wt 
25-30,000 (4) which, in the mouse, has been termed T25 (5, 6). Mutants of classes A, B, 
C, and E synthesize T25 molecules which are structurally different from the wild-type 
glycoprotein and which are not expressed on the cell surface, as determined by both 
biochemical and serological criteria (2, 7). 1 Pulse-chase xperiments showed that the 
mutant molecules are degraded faster than the wild-type molecules; ~however, the 
increased rate of degradation fthe mutant molecules does not seem sufficient to account 
for the 500-1,000-fold deficit of T25 on the cell surface. 
The existence of separate mutant classes, each of which synthesizes a mutant 
T25 molecule which does not reach the cell surface, raises questions about the 
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localization of T25 in mutant vs. wild-type cells and among the different mutant 
classes themselves. The T25 glycoprotein has been isolated from cultured mouse 
lymphoma cells and has been used to prepare a rabbit antiserum which 
specifically reacts with T25. This antiserum has allowed us to use immunohis- 
tochemical methods to detect T25 in wild-type and mutant cells. In the present 
study we have used immunofluorescence and immunoelectron microscopy to 
verify the absence of T25 from the cell membrane of mutant cells and, in 
preliminary experiments, to demonstrate directly the presence ofT25 molecules 
within mutant cells. 
Materials and Methods 
Cell Lines. The wild-type AKR/J lymphoma line BW5147 (Thy 1 ÷) and the class A mutant 
BW5147 (Thy l-a) have been described previously (3, 7). (This mutant cell line was referred to as 
BW5147 (Thy 1-) in previous publications). The cells were grown in suspension culture in 
Dulbecco's modified Eagle's medium with 10% horse serum (8). 
Rabbit Anti-T25. Rabbit antiserum against T25 glycoprotein was prepared by repeated 
subcutaneous injections of the purified glycoprotein in complete Freund's adjuvant. A detailed 
account of the purification of the antigen and the properties of the antiserum will be given 
elsewhere. Briefly, T25 glycoprotein was purified from BW5147 (Thy 1 +) cells by solubilization of 
a crude membrane pellet with sodium deoxycholate, ~actionation on a pea lectin-Sepharose 
column followed by gel filtration (9). The antiserum against T25 glycoprotein was cytotoxic for 
Thy 1 + lymphomas but not Thy 1- mutant cells. One major radioactive species with a 25,000 mol 
wt and corresponding to T25, was specifically precipitated by the antiserum from BW5147 (Thy 
1 +) cells labeled either by the lactoperoxidase urface-labeling technique or metabolically abeled 
with [SH]mannose or [~H]leucine. 
To demonstrate that intracellular staining was specific for T25, the rabbit anti-T25 antiserum 
was absorbed with intact BW5147 (Thy 1 +) cells to remove the anti-T25 antibodies, the remaining 
serum being used as a control. A pellet of 2 × 108 viable cells was incubated with 0.25 ml of a 1:10 
dilution of the antiserum in phosphate-buffered saline for 30 min at room temperature. The cells 
were then centrifuged into a pellet and the supernate removed. This process was repeated three 
times. 
Immunolabeling Reagents, For immunofluorescence staining, an indirect procedure was 
used, employing affinity purified goat antibodies to rabbit IgG. The goat antibodies were 
conjugated with fluorescein isothiocyanate or with lissamine rhodamine B sulfonyl chloride (10). 
For indirect immunoferritin staining, the goat antibodies were conjugated with six times 
recrystallized ferritin by the procedure of Kishida et al. (11). 
Surface Immunofluorescent Labeling of T25 Protein. Both the wild-type and mutant cells 
were first treated in suspension with rabbit antisera to T25 protein in phosphate-buffered saline 
containing 0.2% bovine serum albumin, pH 7.4 for 30 min at 0°C. After washing, the cells were 
then reacted with fluorescein-conjugated goat antibodies to rabbit IgG for 30 min at 0°C. After 
washing the cells free of unbound protein, they were then fixed with 2% formaldehyde in 0.1 M 
phosphate buffer, pH 7.4, for 30 min at 0°C, and examined by fluorescent and Nomarski optics. 
Intracellular Immunofluorescent Labeling of T25 Protein. Wild-type and mutant cells were 
fixed with 0.2% glutaraldehyde in 0.1 M phosphate buffer, pH 7.4 for 45 min at 0°C. Fixed cells 
were then kept overnight in 0.1 M phosphate buffer at 4°C, after which they were infused in 1.2 M 
sucrose, frozen, and sectioned in the frozen state. For immunofluorescent staining, such sectioning 
was carried out at about -30°C to section thicknesses of about 0.2 ~m, whereas for immunoferritin 
staining, sections were cut at -80°C to thicknesses of approximately 700/k (12-14). Both types of 
sections, after thawing, were then stained with rabbit antisera to T25. As controls, some sections 
were treated with normal rabbit IgG. The thicker sections were then treated with rhodamine- 
conjugated goat antibodies to rabbit IgG and processed for fluorescence observations. (Rhodamine 
conjugates were used here rather than fluorescein conjugates because of the autofluorescene of 
the glutaraldehyde-treated cells.) The thinner sections, on electron microscope grids, were labeled 
with ferritin-conjugated goat antibodies to rabbit IgG (13), and observed by electron microscopy. 
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Microscopy. Fluorescence observations were made with Zeiss Photoscope III by using a ×63 
oil immersion lens and an epi-il luminator. Fluorescein and rhodamine fluorescences were excited 
with an Osram HBO 50 W bulb, and the filter combinations CZ 487710 and CZ 487714, 
respectively, were used for observations. Photography was performed with Kodak Plus X film. 
Electron microscopic observations were made with a Phill ips Model 300 electron microscope at 
60 kV. 
Results and Discussion 
In this study we have used immunofluorescent a d immunoelectron micro- 
scopic methods to directly visualize T25 in wild-type and Thy 1- mutant cells. 
The results confirm the interpretation based on serological and biochemical 
methods. The wild-type cell line BW5147 (Thy 1 ÷) when stained in the living 
state by indirect immunofluorescence, by using rabbit anti-T25 as the primary 
reagent, shows T25 clustered over the cell surface (Figs. la and b). No surface 
fluorescence is seen when the class A mutant cell line BW5147 (Thy l-a) is 
stained in a similar manner (Figs. 2a and b). In frozen sections examined by 
immunofluorescence, thewild-type cell line shows staining predominantly at
the cell membrane with areas of weak diffuse cytoplasmic fluorescence (Fig. 3). 
In contrast, the mutant cell line shows only diffuse patchy fluorescence 
throughout the cytoplasm (Fig. 4). This cytoplasmic staining was absent when 
the anti-T25 antiserum was first absorbed with intact Thy 1" cells (data not 
shown). Therefore there was no evidence that the anti-T25 serum contained 
antibodies which recognized contaminating intracellular specificities. Controls 
using normal rabbit serum in place of the antibodies to T25 were always 
negative. 
A similar distribution of T25 was seen by immunofluorescence in mutants of 
classes C and E and their corresponding wild-type lines (data not shown). 
The development of ultrathin frozen sectioning methods of specimen prepa- 
ration for immunoferritin electron microscopy (12, 13) has allowed us to carry 
out preliminary experiments at the ultrastructural level to study the distribu- 
tion of T25 within the cytoplasm as well as on the surfaces of these cells. With 
the wild-type cells, the immunoferritin staining for T25 is mostly on the surface, 
with only light staining in the cytoplasm (Fig. 5). In the mutant cell line, little 
T25 is seen near the cell surface, but substantial mounts are found throughout 
the cytoplasm (Fig. 6). These results are therefore ntirely consistent with the 
immunofluorescent results described. Beyond that, however, it is of interest 
that the immunoferritin staining is often observed in clusters (Fig. 6, arrows) 
extending up to the cytoplasmic face of the surface membrane. This suggests a 
partially vesicular distribution of T25 protein inside the mutant cells, possibly 
extending beyond the endoplasmic reticulum up to the plasma membrane. 
FIG. 1. a) Indirect fiuorescein immunofluorescence staining of the T25 glycoprotein on the 
surfaces of intact BW5147 (Thy 1 +) cells, and b) the same field viewed with Nomarski optics. 
FIG. 2. a) The absence of surface staining for the T25 glycoprotein on intact BW5147 
(Thy l -a) cells, and b) the same field viewed with Nomarski optics. 
FIG. 3. Fixed frozen sections of BW5147 (Thy 1 +) cells stained by indirect rhedamine 
immunofluorescence for the T25 glycoprotein. Note the largely surface staining of the cells. 
FIG. 4. Fixed frozen sections of BW5147 (Thy l -a) cells stained by indirect rhodamine 
immunofluorescence for the T25 glycoprotein, Note that  most of the staining is cytoplasmic. 
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The genetic behavior of the class A, B, C, and E mutants and the fact that 
each mutant of these classes ynthesizes an incomplete T25 molecule suggested 
the hypothesis that the mutants had defects in posttranslational steps of 
biosynthesis. Since T25 is a glycoprotein, the most likely block seemed to be a 
defect in carbohydrate biosynthesis (2, 7). Evidence supporting this idea comes 
from two experimental pproaches. First, biochemical studies on the radiola- 
beled glycopeptides of mutant and wild-type T25 glycoproteins show that the 
oligosaccharides of the mutant molecules differ from those of the wild-type 
molecules. 1 Second, mutants with a Thy 1- phenotype and which complement 
with class E mutants have been selected by prolonged exposure of mutagenized 
wild-type cells to cytotoxic oncentrations of concanavalin A (I. Trowbridge, 
and R. Hyman, unpublished results). The class E mutants how a pleiotropic 
defect which affects the glycosylation ofmany glycoproteins, although only T25 
is absent from the cell surface.1 
Hickman et al. (15) have shown that IgA and IgE-secreting murine myeloma 
cells treated with tunicamycin, an inhibitor of glycosylation, show greatly 
reduced secretion of myeloma protein. By immunofluorescence unglycosylated 
protein is found inside the cells where it is present in a punctate distribution. 
Vesicles formed by the endoplasmic reticulum are seen in the tunicamycin- 
treated cells, and it was suggested that the unglycosylated myeloma protein is 
present mainly in these vesicles, but no immunoelectron microscopic observa- 
tions were made. 
To gain further information from immunoelectron microscopy on the specific 
nature of the blocks in different classes of Thy 1- mutant it will be necessary to
use newly developed methods for positive staining of frozen sections 2 to delineate 
better the internal membranes and ultrastructure of the cell. Furthermore, the 
use of synchronized cell cultures may permit he intracellular pathway of T25 
biosynthesis tobe elucidated. 
Summary 
The wild-type BW5147 (Thy 1 +) cell line and its Thy 1- mutant derivative 
BW5147 (Thy l-a) were examined by immunofluorescence andimmunoelectron 
microscopy for the presence of T25, the glycoprotein which bears the Thy 1 
alloantigen. The wild-type cell had T25 predominantly localized on the cell 
surface. In the mutant cell line, T25 accumulated intracellularly and was 
present in a clustered istribution throughout the cytoplasm. T25 was not 
present on the surface of the mutant cell line in significant amount. 
Received for publication 19 January 1978. 
F~a. 5. Immunoferrit in staining for the T25 glycoprotein on fixed, ultrathin frozen sec- 
tions of BW5147 (Thy 1 +) cells. Note the largely surface localization of the ferritin stain. 
Fro. 6. Immunoferrit in staining for the T25 glycoprotein on fixed, ultrathin frozen sec- 
tions of BW5147 (Thy l -a)  cells. The ferritin stain is largely cytoplasmic and often seen 
in small clusters, up to the plasma membrane. 
2 K. Tokuyasu. Manuscript submitted for publication. 
1354 LOCALIZATION OF T25 IN THY 1- CELLS 
References  
1. Hyman, R., and I. Trowbridge. 1977. Analysis of lymphocyte surface antigen 
expression by the use of variant cell lines. Cold Spring Harbor Syrup. Quant. Biol. 
41:407. 
2. Hyman, R., and I. Trowbridge. 1978. Analysis of the biosynthesis ofT25 (Thy-1) in 
mutant lymphoma cells: a model for plasma membrane glyceprotein biosynthesis. 
Cold Spring Harbor Conference on Differentiation of Normal and Neoplastic 
Hematopoietic Cells. In press. 
3. Hyman, R., and V. Stallings. 1974. Complementation patterns of Thy-1 variants and 
evidence that antigen-loss variants "pre-exist" in the parental population. J Natl. 
Cancer Inst. 52:429. 
4. Barclay, A., M. Letarte-Muirhead, A. Williams, and R. Faulkes. 1976. Chemical 
characterization f the Thy-1 glycoproteins from the membranes of rat thymocytes 
and brain. Nature (Lond.). 262:563. 
5. Trowbridge, I., I. Weissman, and M. Bevan. 1975. Mouse T-cell surface glycoprotein 
recognized by heterologous anti-thymocyte sera and its relationship to Thy-I 
antigen. Nature (Lond). 256:652. 
6. Trowbridge, I., and C. Mazauskas. 1976. Immunological properties of murine 
thymus-dependent lymphocyte surface glycoproteins. Eur. J. Immunol. 6:557. 
7. Trowbridge, I., and R. Hyman. 1975. Thy-1 variants of mouse lymphomas. Biochem- 
ical characterization f the genetic defect. Cell. 6:279. 
8. Horibata, K., and A. Harris. 1970. Mouse myelomas and lymphomas in culture. Exp. 
Cell Res. 60:61. 
9. Trowbridge, I., M. Nilsen-Hamilton, R. Hamilton, and M. Bevan. 1977. Preliminary 
characterization f two thymus-dependent xenoantigens from mouse lymphocytes. 
Biochem. J. 163:211. 
10. Brandtzaeg, P. 1973. Conjugates of immunoglobulin G with different fluorochromes. 
I. Characterization by anionic-exchange chromatography. Seand. J. Immunol. 
2:273. 
11. Kishida, Y., B. Olsen, R. Berg, and D. Prockop. 1975. Two improved methods for 
preparing ferritin-protein conjugates for electron microscopy. J. Cell Biol. 64:331. 
12. Tokuyasu, K. 1973. A technique for ultracryotomy of cell suspensions and tissues. J. 
Cell Biol. 57:551. 
13. Tokuyasu, K., and S. J. Singer. 1976. Improved procedures for immunoferritin 
labelling of ultrathin frozen sections. J Cell Biol. 71:894. 
14. Bourgnignon, L., K. Tokuyasu, and S. J. Singer. 1978. The capping of lymphocytes 
and other cells, studied by an improved method for immunofluorescent staining of 
frozen sections. J Cell Physiol. In press. 
15. Hickman, S., A. Kulczycki, R. Lynch, and S. Kornfeld. 1977. Studies of the 
mechanism of tunicamycin inhibition of IgA and IgE secretion by plasma cells. J. 
Biol. Chem. 252:4402. 
